PTV's Dr Fintan Walton interviews top executives from leading pharmaceutical and biotechnology companies. PharmaTelevision News Review is available on PharmaTelevision to registered users. Register now to get access!

News Review Latest

News Review Archive
Scroll: Previous
Are Medigene
How a collaborative
Will accelerated
RowAnalytics:
BCF: A Different
Karus Therapeutics:
Atlantic
Centauri
One Nucleus: The
Newable: Helping to
GE Healthcare:
Biotech and Money
Green Bone:
Abpro: Creating
Cantargia:
Mission
Chinese University
Bone Therapeutics:
JLINX: A New
Sino-UK Fund: The
Curetis: Care for a
MedCity: Your front
Synaffix: Enables
Sareum: Focused on
Mucosis: Vaccines
Auspherix: Meeting
AmpliPhi: Advancing
Genentech: A
Dimerix: Advancing
Thrive Bioscience:
AusCann: Shaping
Opthea: Developing
Emory Institute for
MTPConnect: The
AdAlta: Developing
RHS: Reproductive
AusBiotech:
Sensorion:
Novithera SAS:
F2G: Advancing
Cellestia Biotech:
Biosceptre: Promise
Anima Biotech:
Senzime: Unique
Lyfebulb: Connect
Saniona: A leading
Ocusweep® Your
AbbVie: A
Is Fusion
Merck Ventures:
Albumedix: A world
Alcyomics: Reducing
New solutions to
Disarming bacteria:
MedImmune: Open,
The Francis Crick
Massachusetts
NIHR: Improving the
Could MGB Biopharma
Gil Gurfinkel, VP,
Mundipharma: A
Midkine Symposium
4th Midkine
Midkine Symposium
Midkine Symposium
Midkine Symposium
Midkine Symposium
Midkine Symposium
Midkine Symposium
Midkine Symposium
KBI Biopharma: How
DelSiTech: What are
Galena BioPharma:
Avexxin: Pioneering
Boehringer
How small decisions
What benefits do
Boehringer
Is Boehringer
Is change is the
Boehringer
How to stop culture
Treeway: Pioneering
AstraZeneca
Why Genentech
Can multi- DARPins
Immunovia:
Can measuring DNA
The story of how UK
Contravir:
Daniela Bellomo, TT
Can Sunergos
Cell and Gene
Biotech and Money
Isis Innovation:
Cambridge
Cancer Research
What makes PsiOxus’
How to harness
Jason Coloma,
Axel Hoos, GSK:
argenx and LEO
Building the bio
Can Ellume’s unique
Bill Primrose, CEO,
Sarah Haywood, CEO,
Chris Mayo,
Paul V. Drohan, CEO
Katya Ascher,
Richard Mason,
Zahid Latif, Head
Jane Dancer, CBO,
Dr. Thomas Mander
Is Cortisol
How Benitec’s
Chris Haskell, Head
Can GSK and Altius
BerGenBio: How EMT
The 'Two Cylinder'
A need for a new
What’s behind
How Sienna Cancer
Can Opal
Laurent Levy, CEO,
Collagen-based cell
How the Biotech
The strategy behind
How the Oslo Cancer
Can ganaxolone
Sprint Biosciences:
How Stockholm
Mevia: How printed
A positive approach
How 18-MC is
MVIC: A one-stop
Gene-Therapy
The right drug, to
Karolinska
AMRA: Facilitating
Is the future of
How Galapagos is
The story behind
Is Targovax going
The NASDAQ capitals
Does your
Pledpharma, helping
Kancera: Focusing
Harriet Fear, One
Jim Greenwood CEO
Steve Bates BIA:
Anthony Holmes,
Neill Moray
Sanofi Pasteur:
Why R&D Innovation
Saroj Velamakanni,
Sven Lee: How
Mike Riley,
Reza Moridi,
Mark Noguchi,
How to solve a key
Is it possible to
Aidan Courtney,
Enrico Bastianelli,
David Phillips,
Holoclar® - The
Why Pluristem
Antoine Papiernik,
Kevin Johnson,
Personalised
Janssen Canada
Developing
Discovering the
F.I.R.S.T.™ - a
Gregory Bonfiglio,
Mattias Johansson,
Save the Cord
Mattias Nystrom,
How Inflection
Dedicated to
Addressing the
It's all about
Driving success by
Build on
AM Pharma and
Why listening to
Why Boehringer
Mike Capaldi,
Alessandro Padova,
Award winning
Are we on the verge
Marco Mohwinckel,
Preparation and
Have we reached a
Funding, supporting
Is evergreen
Can Cell Therapy
Why Lord Digby
Neil Darkes and
Nanobodies-
Dame Sally Davies
How to divide and
Uncovering cutting
Premaitha: changing
U-CAN Project-
Atomo Diagnostics:
Developing novel
Dr Rob Phillips,
Ian Edvalson,
Professor Ira
Professor Frank
How are Polyplus
How close are
Deborah Rathjen,
Australia ranked
Could Phaxan™
Claire Skentelbery,
OssDsign – The New
Dave Pinnington,
Albert van Eijk,
Kay Rispeter,
Irina Osovskaya,
Mike Bellis Pfizer
Tim White,
Felix Jackson,
Kaush Gandhi,
Delivering
How film making is
Fighting Prostate
Applying legal
Beyond antibodies.
Connecting brain
A Dedicated
Why choose Norway
Can PledPharma
Breakthrough
Tim Herpin,
Genentech
Genentech:Napoleone
Genzyme, Stephanie
J&J Innovation,
How do you take
How are ValiRx
“Can cancer cells
AstraZeneca, Shaun
TransCelerate
Marks & Clerk,
How are Sanofi
Is Abzena the new
How BerGen Bio are
How would you spend
What is the
Sunil Shah, CEO,
Can J&J's novel
Regina Hodits,
Christoph Schmidt,
Is TxCell close to
Harnessing J&J's
Pfizer explains
Biotech turns
DuBiotech - Growing
Transforming
Clare Wareing,
The Importance of
Putting the patient
Accelerating the
A front door to the
Creating an urgency
Why Pharma has to
Collaboration - the
Carlos de Sousa,
Changing the rules
Highlighting UK
Why Flanders is a
AstraZeneca:Shaun
Zoetis, a world
A quicker way to
Two Becomes One-
Valeria Uribe,
Converting medical
A novel approach to
Providing a high
Developing
Dedicated to
Jack Bobo, Senior
GW Pharmaceuticals,
Global CEO
Getting closer to
Rainmaker, the
Boehringer
Pharma Innovation
Chris Nave, Brandon
John Holaday, CEO,
Marc Goemans, DSM
Lee Rodney,
Hon. Ian Walker MP
Barry Thomas,
Monika Richter,
Rob de Ree, CEO,
Johannes Sarx, LISA
Katherine Cohen,
David Malek,
Tsipi Keren-Lehrer,
Mel Billingsly,
Kenneth Chien,
Evan Siegel, Ground
Genentech, Kevin
Ontoforce. Peter
Fintan Walton &
Sam Fazeli,
Dr Stelios
BioPeople, Sophie
Noxxon, Aram
AusBiotech, Anna
Bionomics, Deborah
PharmaSynth, Alex
Jonas Ekstrand,
Piyush Unalkat,
Claire Dorrian,
Colin
Award winning
Laurent Levy, CEO,
Dr Ryan Donnelly,
Helen Khulman, Lead
Award winning
Hunt Biosciences,
FundedByMe Equity,
Kevin Johnson,
Michele Ollier,
Anders Ekblom,
Hugh Salter, Head,
F-star, John
Ben Miles,
Lein Applied
NanoSight finds
BIO:The continuing
Kit Malthouse,
Immunocore; Working
Eagle Genomics:
BioIndustry
Johnson & Johnson
Anglonordic Biotech
BerGenBio: Richard
Inflection
Smerud Medical
Forbion’s General
Grant Thornton:
Q Chip: Tim Sparey.
Ockham Oncology’s
EUSA Pharma: Bryan
Avillion: Lewis
Karus Therapeutics
Andrew Casey
Denovo Biomarkers:
Takeda Ventures
Oxford Gene
Creabilis: Eliot
Horizon Discovery &
Life Sciences
Sustainable
Genzyme: Rogerio
KaloBios: David
Johnson & Johnson
Geropharm: Petr
Roche: Sophie
Ysios Capital:
Advanced Cell
Roche: Stefan
Biocat: Montserrat
Telormedix: Johanna
e-Therapeutics:
Genentech: Mike
GSK & Avalon
CIRM: Elona Baum.
AstraZeneca: Morten
TVM Capital: Axel
EMD Serono:
Almirall: Jordi
Aicuris: Prof.
Genmedica: Alec
Johnson & Johnson:
Bayer Healthcare:
Catalent: Sven
Geoff Brooke,
George Millstien,
EBD Group: Carola
Government of
Gene Signal: Eric
Trophos: Christine
MDSL International:
Sunshine Heart :
Takeda: Carlos De
Virttu Biologics:
Alzheimer's
Massachusetts Life
UniQuest : Dr Dean
Innovacell:
Genetic Alliance
Merck & Co: Gregory
Prosensa: Luc
Forbion Capital
Evotec: Cord
Promethera: Eric
DSM Biologics:
Genentech:
AstraZeneca: Tim
Roche: Shafique
Bionomics: Deborah
AusBiotech: Anna
Galapagos: Onno Van
Novo Nordisk :
Forbion Capital
Procter & Gamble:
Allied Healthcare
BaselArea Economic
MacuClear :Philip
Carnot
Tigenix: Maria
AstraZeneca: Shaun
Nina Dudnick,
Anders Ekblom;
TVG: Robert Lee
Hans Preusting:
Reid Leonard :
David de
Holger
Carola Schropp, EBD
Tom Shepherd ,
Robert Coughlin:
The Importance of
Michael Poole,
Garry Neil,
GSK: Ian Tomlinson
Puerto Rico
John Fraher,
Pfizer: Biosimilars
Janssen Research &
Janssen Research &
Johnson & Johnson,
BioCatalyst:
Millennium:Looking
Pear Pugh
Astellas & Merck &
Roche Partnering:
Apex-Brasil:
Genzyme: What Makes
Bionic Vision
DSM
TT Factor: Seeking
BVGH: Bringing
Immunovaccine:
Cytheris:
Medimmune: Joining
AC Immune: Second
Amakem: Targeting
Horizon Discovery;
Index Ventures:
Apposite Capital:
Almac Discovery:
Molecular Partners
4-Antibody:
Sutro Biopharma:
BioLineRx: 'Bench
MPM Capital: Good
Innovation- Merck's
Galapagos: 3
Aram Mangasarian
ProtAffin: A new
Genentech
Technology to
Why AstraZeneca
R&D and Business
Award Winning
Deal Making in
Deal Making in
Deal Making in
Index Ventures, GSK
Great Science
Peter York and Paul
Sunshine Heart:
Brandon Capital
QRx Pharma Ltd:
Polytherics close
BIOTECanada: Peter
CM Capital: Mark
Prosensa: Luc
Benitec: Peter
Bionomics Ltd:
OrthoCell: Paul
GBS Venture
Molmed: Holger
Biosceptre: Cliff
Novo Nordisk: Tomas
Hybrigenics:
Gallus
AstraZeneca: Geoff
AusBiotech: Anna
TVG: Robert
European
BioVista Inc.
Children's Hospital
Astex
AstraZeneca: Shaun
Spinifex: CEO, Tom
Asmacure. CEO,
Genentech Inc:
BioCity CEO, Glenn
Pfizer Inc's Polly
BioBDx: Byron
Kymab: Tom Shepherd
The Promise of
Karin Bryskhe, CEO
Bob Coughlin, CEO
BIA Chairman, Tim
GSK: Mark Wilson
Dr. Jay Tischfield
William Prather, of
Cellzome: Tim
BiondVax
Invida: John Graham
Pfizer: Doug
Merck Research
IDA Ireland: Dave
Syntaxin: Melanie
DSM
Genentech`s James
Roche, Dan
The pharma and drug
Janssen
Psioxus CEO John
BayBio CEO Gail
Konstantinos
Patrick O'Reilley,
Alan Lewis, 2011
Anne Lane,
John Noble,
Francis Gurry,
Anthony Venturino,
Linda Chao of
Blair Jackson of
David Chiswell, CEO
Olivier Litzka of
Marc Van de Craen
Naiyin Wang
Roel Bulthuis of
Bryan Morton tells
Martin Heidecker of
Sunil Shah
Manuel
Martin Buckland
Takeda make a
Greg Wiederrecht,
Damian Maron, CEO
Tim Sparey, Head of
Gregory Moss Smith,
ACT: Accelerating
Henning Afflerbach,
Phillippe
Marco Boorsma
Roche's Approach to
Remi Delansorne,
Kevin Johnson,
Clifford Stocks
Ian Nicholson of
Joaquin Gomez of
Rentschler
BioIndustry
Francesco De
Lilly Ventures: Ed
Kerstin Valinder
Immutep`s
Telormedix’s
Christian Zahnd
Finn Benned Hansen
Luc Dochez on why
Christelle Dagoneau
AusBio Conference
Susan Graff talks
China and Korea -
QRX Pharma: Finding
Andrew Bray
Deborah Rathjen
BioAngels: Dr John
AusBioTech: Dr Anna
BIO: Growth of
Merck & Co and
Immunovaccine`s
BioServe: One of
REGiMMUNE:
LivTech Inc: Dr.
JBA: Setsuo
Canbas: Takumi
MGH & BU: Steven
Roche Partnering:
MassBio: Robert
Chiome: Masa
EDB Group: Carola
Bioniche: Graeme
Seeding Labs: Nina
SIOGEN Biotech:
PharmaVentures
PharmaVentures
PharmaVentures CEO,
Cerenis
BIO Ventures for
London Technology
Reed Smith LLP:
Cancer Research
Bayer Schering
Roche & Genentech: